Mobility in Daily Life and Falls in Parkinson's Disease: Potential for Rehabilitation Trial N/A Completed Nov. 5, 2026
Evaluating the Effect of the Zeen Mobility Device on Clinical Practicality, Safety, and Impact (Via Assessments of Walking, Standing Tolerance, Balance, Endurance, Effort, and Participation in Daily Tasks) in an Outpatient Rehabilitation Setting for Individuals With Mobility Impairments. Trial N/A Not yet recruiting Nov. 5, 2026
Voluntary Activation During Isokinetic Contractions in Subjects With Neuromotor Disorders Trial N/A Completed Nov. 5, 2026
The Effects of Ischemic Conditioning in Individuals With Parkinson's Disease Trial N/A Not yet recruiting Nov. 5, 2026
Treating Anxiety in Parkinson's Disease With a Multi-Strain Probiotic Trial Phase 2 Completed Nov. 5, 2026
Clinical Safety and Efficacy of Umbilical Cord Mesenchymal Stromal Cells-derived Exosomes in Patients With Parkinson's Disease Trial Phase 1 Active, not recruiting Nov. 5, 2026
Adaptive DBS to Offset STN Dysregulation During Exercise in PD Trial N/A Active, not recruiting Nov. 5, 2026
Striatal and Extra-Striatal Cholinergic Terminal Density in LRRK2-PD Mutation Trial N/A Recruiting Nov. 5, 2026
Efficacy, Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of BIA 28-6156 in GBA-PD Trial Phase 2 Completed Nov. 5, 2026
Early Molecular Biomarkers for Differentiating Parkinsonian Syndromes Trial N/A Enrolling by invitation Nov. 5, 2026
Unilateral and Staged Bilateral Pallidothalamic Tractotomy Using Exablate MRgFUS in Advanced Parkinson's Disease. Trial N/A Not yet recruiting Nov. 5, 2026
A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease Trial Phase 3 Recruiting Nov. 4, 2026
Longitudinal Observation of Neurodegeneration in Parkinson's Disease Using Molecular Imaging and Blood Biomarkers Trial N/A Not yet recruiting Nov. 4, 2026
Naturalistic Sleep Assessed by Wearable Devices in Parkinson Disease Trial N/A Completed Nov. 4, 2026
Tributyrin for Progressive Supranuclear Palsy (PSP): Virtual Trial Trial Phase 1 Recruiting Nov. 4, 2026